These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 17263281)
41. [BCG vaccination in the world]. Toida I Kekkaku; 2000 Jan; 75(1):1-7. PubMed ID: 10689812 [TBL] [Abstract][Full Text] [Related]
42. Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union Against Tuberculosis and Lung Disease. Tuber Lung Dis; 1994 Jun; 75(3):179-80. PubMed ID: 7919307 [No Abstract] [Full Text] [Related]
43. [Results and significance of a baseline tuberculin skin test programme among health care workers in a hospital setting]. Gerbaudo L; Violante B Med Lav; 2007; 98(3):221-31. PubMed ID: 17598350 [TBL] [Abstract][Full Text] [Related]
44. Efficacy of the BCG revaccination programme in Hong Kong. Green RA Int J Tuberc Lung Dis; 2001 Dec; 5(12):1161-2. PubMed ID: 11769776 [No Abstract] [Full Text] [Related]
45. [Respiratory syntomatic prevalence, infection and tuberculosis disease and associated factors: population-based study]. García I; De la Hoz F; Reyes Y; Montoya P; Guerrero MI; León CI Biomedica; 2004 Jun; 24 Supp 1():124-31. PubMed ID: 15495580 [TBL] [Abstract][Full Text] [Related]
46. Efforts of identifying the place of tb infection and bcg vaccination in the hygiene hypothesis of allergy. Omiadze K; Telia A; Khechinashvili G Georgian Med News; 2006 Jul; (136):61-5. PubMed ID: 16905848 [TBL] [Abstract][Full Text] [Related]
47. [Prophylaxis of tuberculosis with BCG vaccine in children from contact and from unknown contact]. Khadeeva PV; Mikhaleva LV; Morozov IuA Probl Tuberk Bolezn Legk; 2005; (1):29-32. PubMed ID: 15801633 [TBL] [Abstract][Full Text] [Related]
48. [The current and future situations of TB/HIV (co-infection of tuberculosis and HIV) in Japan]. Yamada N; Nagai H Kekkaku; 2009 Apr; 84(4):203-11. PubMed ID: 19425395 [TBL] [Abstract][Full Text] [Related]
49. Tuberculosis in Thailand: epidemiology and program performance, 2001-2005. Jittimanee S; Vorasingha J; Mad-asin W; Nateniyom S; Rienthong S; Varma JK Int J Infect Dis; 2009 Jul; 13(4):436-42. PubMed ID: 19013094 [TBL] [Abstract][Full Text] [Related]
50. [Preventive measures against tuberculosis in working facilities and companies]. Suzuki K; Satou K Kekkaku; 2007 Mar; 82(3):201-16. PubMed ID: 17444125 [TBL] [Abstract][Full Text] [Related]
51. Assessing BCG vaccination coverage and incidence of paediatric tuberculosis following two major changes in BCG vaccination policy in France. Guthmann JP; Antoine D; Fonteneau L; Che D; Lévy-Bruhl D Euro Surveill; 2011 Mar; 16(12):. PubMed ID: 21457685 [TBL] [Abstract][Full Text] [Related]
52. A public-private partnership for TB control in Timika, Papua Province, Indonesia. Ardian M; Meokbun E; Siburian L; Malonda E; Waramori G; Penttinen P; Lempoy J; Kenangalem E; Tjitra E; Kelly PM Int J Tuberc Lung Dis; 2007 Oct; 11(10):1101-7. PubMed ID: 17945067 [TBL] [Abstract][Full Text] [Related]
53. Comparison of the prevalence of tuberculosis infection in BCG vaccinated versus nonvaccinated school age children. Pulickal AS; Fernandez GV Indian Pediatr; 2007 May; 44(5):344-7. PubMed ID: 17536134 [TBL] [Abstract][Full Text] [Related]
55. HIV infection and multidrug-resistant tuberculosis: the perfect storm. Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830 [TBL] [Abstract][Full Text] [Related]
56. [Should France continue to use BCG?]. Lévy-Bruhl D Rev Prat; 2004 Mar; 54(5):506-8. PubMed ID: 15176508 [TBL] [Abstract][Full Text] [Related]
57. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants. Hesseling AC; Cotton MF; Fordham von Reyn C; Graham SM; Gie RP; Hussey GD Int J Tuberc Lung Dis; 2008 Dec; 12(12):1376-9. PubMed ID: 19017445 [TBL] [Abstract][Full Text] [Related]
58. Electronic tuberculosis surveillance systems: a tool for managing today's TB programs. Nadol P; Stinson KW; Coggin W; Naicker M; Wells CD; Miller B; Nelson LJ Int J Tuberc Lung Dis; 2008 Mar; 12(3 Suppl 1):8-16. PubMed ID: 18302816 [TBL] [Abstract][Full Text] [Related]
59. TB/HIV co infection in Georgia. Gabunia P; Salakaia A; Kiria N; Kandelaki G; Tsertsvadze T Georgian Med News; 2008 Dec; (165):7-10. PubMed ID: 19124909 [TBL] [Abstract][Full Text] [Related]
60. Revising the tuberculosis recording and reporting information system. Norval PY; Heldal E; L'Herminez R; Laserson K; Godfrey A Int J Tuberc Lung Dis; 2008 Mar; 12(3 Suppl 1):17-9. PubMed ID: 18302817 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]